employer cover photo
employer logo
employer logo

Duke Clinical Research Institute

Is this your company?

Duke Clinical Research Institute Reviews

3.5

59% would recommend to a friend

(219 total reviews)
avatar

Adrian Hernandez

82% approve of CEO

55% positive business outlook

Duke Clinical Research Institute has an employee rating of 3.5 out of 5 stars, based on 219 company reviews on Glassdoor which indicates that most employees have a good working experience there. The Duke Clinical Research Institute employee rating is in line with the average (within 1 standard deviation) for employers within the Management and consulting industry (3.7 stars).

Reviews by job title

219 reviews
1.0
30 Mar 2016

Racism, bullying and poor management

Anonymous employee
Recommend
CEO approval
Business outlook

Pros

DCRI is a part of the prestigious Duke name and is organizationally embraced by the esteem of Duke's well known School of Medicine. Great sick and vacation time benefits.

Cons

Racism is persistent at DCRI - so much so that it will make you wonder if this is unique to being in the South and working at Duke or is this really just indicative of the white dominated research industry, as a whole, is all about. Black people are promoted at a much lower rate than their white counterparts and often times hired at lower levels, making it many years the more harder to get to a certain level or reach a level III position in their job title. Management is allowed to lie in "counseling notes" (these are DCRI punitive write ups) to further keep blacks, and anyone else deemed to be less than, below and under any sort of a progressive career track. Managers are hired because they are friends of someone first, and not because of skill and competency. Physicians at DCRI can do pretty much anything they want, even if it means handicapping a trial's success and undercutting clinical operations staff responsible for certain tasks on a project that the physicians are not responsible for.

1.0
25 Jan 2020
Recommend
CEO approval
Business outlook

Pros

Duke’s 403-b employer retirement contributions are attractive. The ability to work with Duke faculty on leading edge science can be very rewarding.

Cons

#1. DCRI's rainmakers have left the building. The key faculty members who attracted profitable industry-sponsored research a decade ago are no longer with the DCRI. Without a significant mix of high-margin commercial research projects, the DCRI’s business model is not sustainable – more layoffs are inevitable. #2. Minimal investment over the past ten years in modern information technology and automation. Without a war chest to make the necessary improvements, nor an organization willing to change - the DCRI will continue to fall further behind its growing list of competitors. #3. A government heavy revenue stream is unsustainable. When the United States’ federal deficit hawks reawaken, or the current administration’s mission to de-fund spending on science reaches the NIH – the flow of government funds will dry up. Underbidding government work in order to keep the doors open is not a sound business strategy, long-term underbidding is unsustainable. #4. The DCRI naiveté. Statements like: “The DCRI launched a strategic planning effort in response to changes occurring across the clinical research industry.” Other CROs are doing very well financially and have been keeping pace with the changing market, they are hiring, not laying off. #5. The DCRI’s operating model is based on a twenty-year old direct labor pricing model. The world has changed; direct labor is no longer the primary cost driver in the age of digital research. A revenue model based solely on direct labor costs cannot make the necessary investments in technology to be competitive in the digital world - further evidence of an unsustainable business model. #6. The DCRI is a career killer. Don’t accept lower pay to get your foot in the door, you will be stuck in the same position for eternity, getting 2% annual increases for as long as you stick it out. Promotions will be very rare events in a collapsing organization.

avatar
Duke Clinical Research Institute Response
6y
Thank you for sharing your thoughts with us. Understandably, we disagree with your outlook for DCRI’s future, yet we appreciate your passion. As an academic research organization (ARO), we pride ourselves on working in a mission-based institute that is shaped by more than 125 dedicated faculty who develop clinical research based on the chronic diseases they treat each day at our hospital and clinics. The world’s largest commercial pharmaceutical companies and federal health institutes rely on the DCRI as a trusted partner to lead the way—taking the first steps—in how clinical research should be done. We get to work on some of the most forward-thinking and interesting research being conducted today; we have the opportunity to test innovative methods, especially in the areas of real-word evidence and pragmatic approaches. We are especially proud of the work we do on government grants, which is some of the most rewarding work our teams get to lead. It’s in this spirit that we fully understand that an ARO is not for everyone, but it is for those who approach each day with an unwavering belief that we can change patients’ lives, no matter the challenges we face in the day-to-day design and implementation of clinical trials and studies. Finally, we’re not alone. The DCRI is a part of the Duke School of Medicine and Duke’s larger health system. This association provides great benefits and flexibility, as well as a large playing field for finding ways to advance your career. Again thank you for taking time to share your thoughts and we wish you well in your career.
1.0
4 Jan 2019
Recommend
CEO approval
Business outlook

Pros

* The mission...if you can ever deliver on it with accuracy and on-time which is rare. * The health care coverage and PTO are good. However they tout all the other "benefits" they feel compensates for the lower pay scale such as children tuition assistance but if you don't have children, this is a meaningless benefit.

Cons

* No strategic vision or plan for DCRI or within the departments * Siloed work groups - lack of true collaboration * The pay is a joke. Well below the average for this area. 2% annual raise across the board (if you're lucky) and no bonuses. * Constant disputes among the Senior leadership team - everyone has their own agenda. No cohesive goal or vision. * Unrealistic expectations - DCRI wants to compete with the organizations like IQVia, PPD, INC, etc. but lack but the vision, technology, and skill sets to do so.

avatar
Duke Clinical Research Institute Response
7y
Thank you for taking the time to provide your feedback. Every day, DCRI’s faculty and staff are focused on developing and sharing knowledge to improve patient care through innovative clinical research. To achieve our mission and plan for a vibrant future, we recognize the need to make business-critical changes that help us meet—and exceed—the needs of our customers and our employees. Over the past two years, we have been working on a number of initiatives to transform the way we do business by optimizing our technology and processes that not only enable us to work smarter, but work better together. Now, with a strong focus on strategic planning and operational diligence, the stage is set for us to make the further changes necessary to succeed. It can take time to see the fruits of our labor and sometimes these changes are not always readily visible, but they are creating a shift in what we do and how we do it. I can assure you that our senior leadership is fully engaged and hope that in the months to come you will begin to see this shift and be a part of the change. Lesley H. Curtis, PhD, Interim Executive Director ________________________________________
Viewing 1 - 3 of 219 Reviews

Glassdoor has 249 Duke Clinical Research Institute reviews submitted anonymously by Duke Clinical Research Institute employees. Read employee reviews and ratings on Glassdoor to decide if Duke Clinical Research Institute is right for you.